drug

mfolfirinox

1 story · latest Sep 17, 2026

Status: Investigational
Trials: 4 registered trials in coverage

Relationships

Developed by BioNTech SE

Developed by Roche

Developed by Incyte Corporation

Timeline

UVA registers Phase 1b/2 trial of Verastem's avutometinib/defactinib in pancreatic cancer

Sep 17Trial updateavutometinib defactinib

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.